Recursion, a biotech company focused on AI drug discovery, secures investment from Nvidia
A man wearing a mask walks past a Nvidia logo in Taipei, Taiwan. Sopa Images | Lightrocket | Getty Images Chip manufacturer Nvidia is set to invest $50 million in Recursion Pharmaceuticals to accelerate the development of the biotech firm’s cutting-edge artificial intelligence models for drug discovery. The joint announcement by both companies on Wednesday …